Andrew L Feldman

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi Clonal relationship between precursor T-lymphoblastic leukaemia/lymphoma and Langerhans-cell histiocytosis
    Andrew L Feldman
    Laboratory of Pathology, National Cancer Institute, Bethesda, MD 20892, USA
    Lancet Oncol 6:435-7. 2005
  2. ncbi Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma
    Christian Gulmann
    National Cancer Institute Food and Drug Administration Clinical Proteomics Program, Laboratory of Pathology, Bethesda, MD 20892, USA
    Clin Cancer Res 11:5847-55. 2005
  3. pmc Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases
    Haipeng Shao
    Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Mod Pathol 24:1421-32. 2011
  4. pmc Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone
    Andrew L Feldman
    Laboratory of Pathology, National Cancer Institute, Bethesda, MD 20892 1500, USA
    Blood 111:5433-9. 2008
  5. pmc Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements
    Rebecca L King
    Department of Laboratory Medicine and Pathology Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN Hematopathology Section, Laboratory of Pathology, National Cancer Institute, Bethesda, MD Department of Pathology, David Geffen School of Medicine, University of California, Los Angeles, CA Division of Hematopathology, University of Pittsburgh Medical Center, Pittsburgh, PA Department of Pathology and Laboratory Medicine, United Health Services Hospitals, Johnson City Binghamton Department of Pathology and Laboratory Medicine, Centrex Clinical Laboratories, Utica, NY Department of Clinical Pathology, Cleveland Clinic, Cleveland, OH Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL Department of Pathology, Duke University, Durham, NC
    Am J Surg Pathol 40:36-43. 2016
  6. ncbi CD10 immunohistochemical staining enhances the histological detection of endometriosis
    Clariss Potlog-Nahari
    Pediatric and Reproductive Endocrinology Branch, National Institute of Child Health and Human Development, Bethesda, Maryland 20892 1583, USA
    Fertil Steril 82:86-92. 2004
  7. ncbi Histiocytic sarcoma after acute lymphoblastic leukaemia: a common clonal origin
    Andrew L Feldman
    Laboratory of Pathology, National Cancer Institute, Bethesda, MD 20892, USA
    Lancet Oncol 5:248-50. 2004
  8. ncbi Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy
    Andrew L Feldman
    Surgical Metabolism Section, Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Clin Oncol 21:4560-7. 2003
  9. pmc Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer
    Christos Sotiriou
    Division of Clinical Sciences, Advanced Technology Center, National Cancer Institute, National Institutes of Health, Gaithersburg, USA
    Breast Cancer Res 4:R3. 2002
  10. ncbi Aggressive Langerhans cell histiocytosis following T-ALL: clonally related neoplasms with persistent expression of constitutively active NOTCH1
    Scott J Rodig
    Department of Pathology, Brigham and Women s Hospital, Boston, Massachusetts, USA
    Am J Hematol 83:116-21. 2008

Collaborators

Detail Information

Publications10

  1. ncbi Clonal relationship between precursor T-lymphoblastic leukaemia/lymphoma and Langerhans-cell histiocytosis
    Andrew L Feldman
    Laboratory of Pathology, National Cancer Institute, Bethesda, MD 20892, USA
    Lancet Oncol 6:435-7. 2005
  2. ncbi Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma
    Christian Gulmann
    National Cancer Institute Food and Drug Administration Clinical Proteomics Program, Laboratory of Pathology, Bethesda, MD 20892, USA
    Clin Cancer Res 11:5847-55. 2005
    ..Proteomic end points should be incorporated in larger, multicenter trials to validate the clinical utility of these protein microarray findings...
  3. pmc Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases
    Haipeng Shao
    Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Mod Pathol 24:1421-32. 2011
    ..Our study provides evidence for transdifferentiation of CLL/SLL B cells to tumors of dendritic and less often histiocytic lineage, and suggests that secondary genetic events may play a role in this phenomenon...
  4. pmc Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone
    Andrew L Feldman
    Laboratory of Pathology, National Cancer Institute, Bethesda, MD 20892 1500, USA
    Blood 111:5433-9. 2008
    ..1 was seen in all cases tested. These results provide evidence for a common clonal origin of FL and H/DC neoplasms when occurring in the same patient, and suggest that lineage plasticity may occur in mature lymphoid neoplasms...
  5. pmc Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements
    Rebecca L King
    Department of Laboratory Medicine and Pathology Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN Hematopathology Section, Laboratory of Pathology, National Cancer Institute, Bethesda, MD Department of Pathology, David Geffen School of Medicine, University of California, Los Angeles, CA Division of Hematopathology, University of Pittsburgh Medical Center, Pittsburgh, PA Department of Pathology and Laboratory Medicine, United Health Services Hospitals, Johnson City Binghamton Department of Pathology and Laboratory Medicine, Centrex Clinical Laboratories, Utica, NY Department of Clinical Pathology, Cleveland Clinic, Cleveland, OH Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, FL Department of Pathology, Duke University, Durham, NC
    Am J Surg Pathol 40:36-43. 2016
    ..These morphologic findings and our previous outcome data suggest that ALK-positive ALCLs and DUSP22-rearranged ALCLs represent prototypical ALCLs, whereas ALCLs lacking rearrangements of both DUSP22 and ALK require further study. ..
  6. ncbi CD10 immunohistochemical staining enhances the histological detection of endometriosis
    Clariss Potlog-Nahari
    Pediatric and Reproductive Endocrinology Branch, National Institute of Child Health and Human Development, Bethesda, Maryland 20892 1583, USA
    Fertil Steril 82:86-92. 2004
    ..To determine whether the use of CD10 immunohistochemistry in addition to hematoxylin and eosin (H&E) staining would increase the sensitivity of surgically suspected endometriosis lesions...
  7. ncbi Histiocytic sarcoma after acute lymphoblastic leukaemia: a common clonal origin
    Andrew L Feldman
    Laboratory of Pathology, National Cancer Institute, Bethesda, MD 20892, USA
    Lancet Oncol 5:248-50. 2004
  8. ncbi Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy
    Andrew L Feldman
    Surgical Metabolism Section, Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Clin Oncol 21:4560-7. 2003
    ..We evaluated the peritoneal progression-free and overall survival (PFS and OS, respectively) for patients with peritoneal MM after surgical resection and regional chemotherapy...
  9. pmc Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer
    Christos Sotiriou
    Division of Clinical Sciences, Advanced Technology Center, National Cancer Institute, National Institutes of Health, Gaithersburg, USA
    Breast Cancer Res 4:R3. 2002
    ..Our goal was to determine the feasibility of obtaining representative expression array profiles from limited amounts of tissue and to identify those expression profiles that correlate with treatment response...
  10. ncbi Aggressive Langerhans cell histiocytosis following T-ALL: clonally related neoplasms with persistent expression of constitutively active NOTCH1
    Scott J Rodig
    Department of Pathology, Brigham and Women s Hospital, Boston, Massachusetts, USA
    Am J Hematol 83:116-21. 2008
    ..Persistent expression of NOTCH1 in such tumors suggests that Notch pathway inhibitors could have a role in the treatment of these unusual neoplasms...